Question Bank › Richer on arrival: the business now flowing in c

Richer on arrival: the business now flowing in carries better economics than the blend the numbers show

Calls Tested
497
Answered YES
25
Hit Rate
5%
rare by design

Fresenius Medical Care AG & Co. KGaA (FMS) — this company's answers

NO on the Q2 2018 call 2018-07-31 C
The model's full reasoning — Q2 2018 call → NOWe need answer YES or NO based on transcript. Need determine if management conveys that business now arriving/ramping carries better economics than blended results, and reported numbers understate because mix with older base or temporary costs. Let's analyze transcript. Key topics: Calcimimetics transition from Part D to Part B, pharmacy to clinics. They mention margin improvement in Care Coordination, revenue decline as expected. Calcimimetics evolving, two quarters into 2-4 quarter process. This is a medical decision, titration. They have costs? They mention lower revenue per treatment from commercial payers, high implicit price concessions, implementation of PAMA oral-only Calcimimetics, small cost increase. They guide operating earnings effect of Calcimimetics net basis around $1 loss for year. Revenue and cost per treatment affected. This is a transition that is ongoing, but is it "incoming business carries better economics"? Calcimimetics is moving from Part D to Part B, pharmacy to clinics. This is a change in reimbursement/payment. It seems to be a headwind, not better economics. They say "Calcimimetics; they continue to evolve... moving from Part D in David to Part B in Barry. Pharmacy to the clinics. We believe that we're probably two quarters in to two to four quarter process in order to get this sorted out with great clarity in detail." This is a transition with costs, but not necessarily better economics. They expect net loss $1 for year. So not richer. Other incoming business: NextStage acquisition? They mention next stage closing on track for second half. But not yet closed, so not arriving. No economics described. Products business: North American products business strong performance. But is it better economics than base? They mention solid organic growth. Not necessarily better economics. Care Coordination margin improvement: They had margin 6.7%, improved. But revenue decline. They sold Sound. Not incoming business. Global Efficiency Program: savings, but not incoming business. ESRD PPS draft rule increase 1.7% - not incoming business.

← Back to the full FMS analysis

Show the exact prompt the model was given
Using ONLY the supplied earnings call transcript and no outside information: On this call, does management convey that the business NOW ARRIVING OR RAMPING at the company carries BETTER ECONOMICS than the blended results being reported — and that the reported numbers understate the company because they mix this richer incoming business with an older, lower-economics base or with temporary costs of scaling into it? Answer YES when management's own words convey, in whatever form fits the business, BOTH halves of ONE coherent story as a present-tense reality: (1) THE INCOMING BUSINESS IS REAL AND ECONOMICALLY RICHER. Management describes business that is actually arriving, ramping, or recently begun — real orders, customers, contracts, volumes, locations, products, or activity now flowing, not pipeline, hopes, or market opportunity — AND indicates that this newer business is economically better for the company than the base it is joining: better margins, better pricing or terms, lower cost to serve, faster payback, richer mix, better unit economics, or profitability the older business did not have. The comparison must be against the company's OWN existing or reported blend, expressed in whatever terms fit the industry, and grounded in what is actually being earned or booked now rather than in targets or models. (2) THE REPORTED NUMBERS ARE A LAGGING BLEND, AND MANAGEMENT SAYS SO. Management conveys, directly or plainly in substance, that the results being reported do not yet show these richer economics — because the new business is still a small share of the mix, because it began recently or mid-period, or because current results also carry identifiable costs of ramping, scaling, onboarding, or standing up that new business ahead of its revenue — so that as the mix naturally shifts and the ramp matures, results improve from what is already in motion rather than from anything still to be won. Answer NO if the improved economics are only targeted, planned, modeled, or hoped for rather than already being realized on real incoming business. NO if the better economics come chiefly from passing through cost inflation, favorable commodity or market prices the company passively receives, or one-time items. NO if the new business is described but management gives no indication it is economically better than the existing blend. NO if the richer business is already the dominant share of results, with no meaningful mix shift or ramp still ahead. NO if the company is chiefly explaining weakness, cutting costs on a shrinking business, or defending a struggling core. NO if the improvement depends mainly on market recovery, new demand not yet secured, or decisions not yet made. NO if the idea appears only in an analyst's question or model that management does not itself affirm. Use only the supplied transcript. Answer only YES or NO.

Companies that answered YES

TickerCompanyCallDateCall grade
ECPG Encore Capital Group, Inc. Q1 2024 2024-05-08 B
ASB Associated Banc-Corp Q1 2024 2024-04-25 A
HUYA HUYA Inc. Q4 2023 2024-03-19 C
GIII G-III Apparel Group, Ltd. Q4 2024 2024-03-14 C
AKYA Akoya Biosciences, Inc. Q2 2023 2023-08-07 C+
SPT Sprout Social, Inc. Q2 2023 2023-08-04 B+
CTO CTO Realty Growth, Inc. Q2 2023 2023-07-28 B
GVP GSE Systems, Inc. Q1 2023 2023-05-15 D
CARS Cars.com Inc. Q1 2023 2023-05-06 B
CRBG Corebridge Financial, Inc. Q4 2022 2023-02-22 B
TMCI Treace Medical Concepts, Inc. Q2 2022 2022-08-13 B+
FLR Fluor Corporation Q2 2022 2022-08-05 D
OGI OrganiGram Holdings Inc. Q3 2022 2022-07-14 B+
BFIN BankFinancial Corporation Q1 2022 2022-05-06 A
LC LendingClub Corporation Q4 2021 2022-01-26 A
EHTH eHealth, Inc. Q2 2021 2021-07-29 F
ADSK Autodesk, Inc. Q3 2019 2018-11-20 A
CUBI Customers Bancorp, Inc. Q3 2018 2018-10-26 C+
ESS Essex Property Trust, Inc. Q2 2018 2018-08-03 B+
IRT Independence Realty Trust, Inc. Q2 2018 2018-08-02 B
SATS EchoStar Corporation Q1 2018 2018-05-10 C+
ALLY Ally Financial Inc. Q1 2018 2018-04-26 B+
ATI Allegheny Technologies Incorporated Q1 2018 2018-04-24 B
FLEX Flex Ltd. Q1 2018 2017-07-28 F
DAN Dana Incorporated Q1 2017 2017-05-02 B

How the model reasoned

SPT · Q2 2023 → YESThe question is about whether management conveys that the incoming business has better economics than the blended results, and that reported numbers understate the company because they mix richer inco...YES Management describes real, incoming business (enterprise growth to 43% of ARR, Tagger acquisition, premium attach rates, mid-market unit economics) that is economically richer than the existing blend, with deprioritization of lower-quality low-end ARR.
AKYA · Q2 2023 → YESThe question is: Does management convey that the business NOW ARRIVING OR RAMPING at the company carries BETTER ECONOMICS than the blended results being reported — and that the reported numbers unders...
CRBG · Q4 2022 → YESThe question is: Does management convey that the business NOW ARRIVING OR RAMPING at the company carries BETTER ECONOMICS than the blended results being reported — and that the reported numbers unders...

More from the question bank

Doing it our way nowSelling out of one thing at a timeThe lull that never cameCrossed from claiming to demonstratingFixed price, unfixed volumeEverything is being bought forwardAll questions →
Not investment advice. Artul.ai publishes AI-generated earnings-call quality grades and expected-volatility estimates — never buy or sell recommendations. We tested over 1,600 predictive hypotheses against 165,000 transcripts; the honest result, including what failed, is documented in our methodology.